207 related articles for article (PubMed ID: 20381119)
21. Expression and clinical significance of CD147 in genitourinary carcinomas.
Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD
J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191
[TBL] [Abstract][Full Text] [Related]
22. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
23. [Expression of peroxisome proliferator-activated receptor-gamma in human pituitary adenomas and its correlation to tumor invasiveness].
Huang CX; Hou YH; Zhao JN; Wang YT; Li JJ; Wen L
Ai Zheng; 2008 Jun; 27(6):590-4. PubMed ID: 18570731
[TBL] [Abstract][Full Text] [Related]
24. [Expression of pituitary tumor transforming gene, endostatin, and basic fibroblast growth factor mRNAs in invasive pituitary adenomas].
Chen L; Liu YS; Wang LS; Yin HG; Hou QT; Liu ZX; Chen LH; Ling F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):651-3, 666. PubMed ID: 16114549
[TBL] [Abstract][Full Text] [Related]
25. [Preliminary study of p16 gene expression in pituitary adenomas].
Yu WH; Hui GZ; Wang Q; Wu SR
Ai Zheng; 2003 Feb; 22(2):198-201. PubMed ID: 12600300
[TBL] [Abstract][Full Text] [Related]
26. Biologic markers of invasive pituitary adenomas involving the sphenoid sinus.
Gandour-Edwards R; Kapadia SB; Janecka IP; Martinez AJ; Barnes L
Mod Pathol; 1995 Feb; 8(2):160-4. PubMed ID: 7777477
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas.
Niveiro M; Aranda FI; Peiró G; Alenda C; Picó A
Hum Pathol; 2005 Oct; 36(10):1090-5. PubMed ID: 16226108
[TBL] [Abstract][Full Text] [Related]
28. Expression and structure of interleukin 4 receptor (IL-4R) complex in human invasive pituitary adenomas.
Chen L; Liu Y; Hou Y; Kato Y; Sano H; Kanno T
Neurosci Lett; 2007 Apr; 417(1):30-5. PubMed ID: 17398005
[TBL] [Abstract][Full Text] [Related]
29. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
[TBL] [Abstract][Full Text] [Related]
30. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.
Zhong WD; Han ZD; He HC; Bi XC; Dai QS; Zhu G; Ye YK; Liang YX; Qin WJ; Zhang Z; Zeng GH; Chen ZN
Oncology; 2008; 75(3-4):230-6. PubMed ID: 18852494
[TBL] [Abstract][Full Text] [Related]
31. Expression of hepatocyte growth factor and its receptor c-Met in human pituitary adenomas.
Hou XZ; Liu W; Fan HT; Liu B; Pang B; Xin T; Xu SC; Pang Q
Neuro Oncol; 2010 Aug; 12(8):799-803. PubMed ID: 20200025
[TBL] [Abstract][Full Text] [Related]
32. CD147 (EMMPRIN) and matrix metalloproteinase-2 expression in uterine endometrioid adenocarcinoma.
Stewart CJ; Crook ML
Pathol Res Pract; 2011 Jan; 207(1):30-6. PubMed ID: 21144675
[TBL] [Abstract][Full Text] [Related]
33. A classification tree approach for pituitary adenomas.
Righi A; Agati P; Sisto A; Frank G; Faustini-Fustini M; Agati R; Mazzatenta D; Farnedi A; Menetti F; Marucci G; Foschini MP
Hum Pathol; 2012 Oct; 43(10):1627-37. PubMed ID: 22446019
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.
Lee JI; Jin BH; Kim MA; Yoon HJ; Hong SP; Hong SD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):678-84. PubMed ID: 19272813
[TBL] [Abstract][Full Text] [Related]
35. Pituitary adenomas. Correlation of the cytologic appearance with biologic behavior.
Pegolo G; Buckwalter JG; Weiss MH; Hinton DR
Acta Cytol; 1995; 39(5):887-92. PubMed ID: 7571965
[TBL] [Abstract][Full Text] [Related]
36. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
[TBL] [Abstract][Full Text] [Related]
37. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production.
Zhu P; Ding J; Zhou J; Dong WJ; Fan CM; Chen ZN
Arthritis Res Ther; 2005; 7(5):R1023-33. PubMed ID: 16207318
[TBL] [Abstract][Full Text] [Related]
38. Epithelial expression of extracellular matrix metalloproteinase inducer/CD147 and matrix metalloproteinase-2 in neoplasms and precursor lesions derived from cutaneous squamous cells: An immunohistochemical study.
Ayva SK; Karabulut AA; Akatli AN; Atasoy P; Bozdogan O
Pathol Res Pract; 2013 Oct; 209(10):627-34. PubMed ID: 23948694
[TBL] [Abstract][Full Text] [Related]
39. Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha.
Wolfsberger S; Wunderer J; Zachenhofer I; Czech T; Böcher-Schwarz HG; Hainfellner J; Knosp E
Acta Neurochir (Wien); 2004 Aug; 146(8):831-9. PubMed ID: 15254805
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases.
Miyabe S; Okabe M; Nagatsuka H; Hasegawa Y; Inagaki A; Ijichi K; Nagai N; Eimoto T; Yokoi M; Shimozato K; Inagaki H
J Oral Maxillofac Surg; 2009 Jul; 67(7):1432-41. PubMed ID: 19531414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]